Comparative analysis of quality of life in patients treated with canagliflozine or DPP-IV inhibitor
The article investigates the value of canagliflozin in the management of type 2 diabetes mellitus from the perspective of a clinically-based patient-centred approach. It focusses on the outcomes of a 52-week double-blind, active-controlled study. The results of this clinical trial demonstrate that c...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2016-12-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://dia-endojournals.ru/dia/article/viewFile/7949/6123 |